Winston Medical Supply CoROCO:6817 -0.17%85 EBITDA Margin % is 22.71% as of Dec. 2025, which is 9% below its 10-year median of 24.87. GuruFocus rates ROCO:6817 with a GF Score™ of 85/100 and a GF Value™ of NT$102.51 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 952 Drug Manufacturers companies, Winston Medical Supply Co ranks better than 77.94% on this metric.
Winston Medical Supply Co (ROCO:6817) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Winston Medical Supply Co EBITDA Margin % Related Terms
Winston Medical Supply Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Winston Medical Supply Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Winston Medical Supply Co EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Winston Medical Supply Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Winston Medical Supply Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Winston Medical Supply Co (ROCO:6817) has a EBITDA Margin % of 22.71% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Winston Medical Supply Co and its competitors. This is near median its historical median of 24.87. Over the past decade, Winston Medical Supply Co's EBITDA Margin % has ranged from 4.52 to 32.20. According to the industry distribution chart, Winston Medical Supply Co ranks #210 out of 952 companies in the Drug Manufacturers industry, placing it in the top 22.1%.
Is Winston Medical Supply Co's EBITDA Margin % too high?
Winston Medical Supply Co's current EBITDA Margin % of 22.71% is near median its 10-year median of 24.87. Over the past 10 years, this metric has ranged from a low of 4.52 to a high of 32.20. The Drug Manufacturers industry median EBITDA Margin % is 12.47. Winston Medical Supply Co's value of 22.71% is 82.1% above this industry median. Based on the distribution chart, Winston Medical Supply Co ranks #210 out of 952 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Winston Medical Supply Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Winston Medical Supply Co's EBITDA Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Winston Medical Supply Co ranks #210 out of 952 companies for EBITDA Margin %. This places Winston Medical Supply Co in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 12.47. Winston Medical Supply Co's value of 22.71% is 82.1% above this benchmark. Historically, Winston Medical Supply Co's own EBITDA Margin % has ranged from 4.52 to 32.20 over the past decade. While the company's 10-year median is 24.87 vs. the industry median of 12.47, Winston Medical Supply Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.47, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Winston Medical Supply Co's current EBITDA Margin % of 22.71% is 82.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Winston Medical Supply Co and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Winston Medical Supply Co's current EBITDA Margin % is 22.71%, which is near median its own 10-year median of 24.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Winston Medical Supply Co stock overvalued right now?
Based on GuruFocus' analysis, Winston Medical Supply Co (ROCO:6817) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$102.51, compared to a current price of NT$59.90 — trading 41.6% below its estimated fair value. The current EBITDA Margin % is 22.71%, which is near median its 10-year median of 24.87 and 82.1% above the Drug Manufacturers industry median of 12.47. Winston Medical Supply Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Winston Medical Supply Co (ROCO:6817), the current EBITDA Margin % is 22.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Winston Medical Supply Co (ROCO:6817) Overvalued in 2026?
Based on GuruFocus' analysis, Winston Medical Supply Co stock appears to be undervalued.
The current stock price of NT$59.90 is trading 41.6% below its estimated GF Value™ of NT$102.51.
GuruFocus considers Winston Medical Supply Co to be Significantly Undervalued.
Key valuation signals for ROCO:6817:
EBITDA Margin %: 22.71% (near median its 10-year median of 24.87)
GF Value™: NT$102.51 vs. price of NT$59.90 (41.6% below fair value)
Industry Position: 82.1% above the Drug Manufacturers median (#210 of 952)
No single metric tells the full story. See the ROCO:6817 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Winston Medical Supply Co Ltd is a manufacturer of medical products. It produces sterile ophthalmic preparations, hormone preparations and healthy products.
85GF Score
Get the complete analysis for ROCO:6817
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6817 has been successfully added to your 
